Genelux Corporation (GNLX) Balance Sheet

NASDAQ: GNLXAssets, liabilities, debt and equity over 7 years.

GNLX balance sheet, 2025

December 31, 2025 · U.S. dollars

$19.0M assets = $7.5M liabilities + $11.5M equity

What it owns$19.0MCash & ST investments: $14.6M (76.7%)Cash & ST investments$14.6M · 77%Other current: $535,000 (2.8%)PP&E: $3.8M (19.7%)PP&E$3.8M · 20%Other non-current: $144,000 (0.8%)=How it is financed$19.0MCurrent liabilities: $6.2M (32.7%)Current liabilities$6.2M · 33%Other LT liabilities: $1.3M (6.6%)Other LT liabilities $1.3MShareholders’ equity: $11.5M (60.7%)Shareholders’ equity$11.5M · 61%

Both columns are drawn to the same scale: what GNLX owns equals what it owes plus shareholders’ equity. Hover a block for its value.

GNLX financial health

Current ratio2.43
Comfortable · current assets cover current liabilities 2.43×
Debt / equity0.15
Low leverage · $0.15 of debt for each $1 of equity
Equity / assets60.7%
Equity-funded · of assets funded by shareholders
Cash / debt866.2%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

GNLX balance sheet trends, 2019–2025

Genelux Corporation balance sheet trends
MetricTrendThenLatestChange
Total assets$3.3M2019$19.0M2025+34.0%/yr
Total liabilities$28.1M2019$7.5M2025−19.8%/yr
Shareholders’ equity−$24.8M2019$11.5M2025—
Cash & short-term investments$425,0002019$14.6M2025+80.3%/yr
Total debt$18.0M2019$1.7M2025−32.6%/yr
Net cash (debt)−$17.5M2019$12.9M2025+$30.5M
Working capital−$14.2M2019$8.9M2025+$23.1M
Book value per share−$1.052019$0.312025—
Current ratio0.0420192.432025+2.39
Debt / equity0.1320230.152025+0.02
Shares outstanding23.6M201937.2M2025+7.9%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

GNLX assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

GNLX liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

GNLX debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

GNLX balance sheet

Genelux Corporation annual balance sheet
2025202420232022202120202019
Assets
Cash & short-term investments$14.6M$30.9M$23.2M$397,000$4.5M$11.3M$425,000
Cash & equivalents$5.3M$8.6M$9.4M$397,000$4.5M$11.3M$425,000
Short-term investments$9.3M$22.3M$13.8M$0———
Receivables$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0
Other current assets$535,000$653,000$1.0M$1.5M$1.3M$127,000$126,000
Total current assets$15.1M$31.5M$24.2M$1.9M$5.8M$11.5M$551,000
Property, plant & equipment (net)$3.8M$3.1M$3.6M$2.0M$2.2M$2.5M$2.6M
Goodwill & intangible assets$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0
Other non-current assets$144,000$92,000$92,000$1.7M$92,000$80,000$80,000
Total assets$19.0M$34.7M$27.9M$5.5M$8.1M$14.0M$3.3M
Liabilities
Accounts payable$4.4M$5.6M$3.8M$6.8M$4.5M$927,000$3.6M
Short-term debt$427,000$329,000$653,000$16.7M$6.6M$3.9M$4.6M
Deferred revenue———$170,000$4.5M——
Total current liabilities$6.2M$6.9M$6.6M$31.6M$22.5M$14.5M$14.7M
Long-term debt$0$0$0$8.5M$18.0M$21.7M$0
Lease obligations$1.7M$1.9M$2.5M$1.4M$1.1M$761,000—
Other long-term liabilities$1.3M$1.5M$1.9M$1.2M$731,000$476,000$13.4M
Total liabilities$7.5M$8.4M$8.4M$41.3M$41.2M$36.7M$28.1M
Shareholders' equity
Common stock & paid-in capital$38,000$35,000$27,000$9,000$9,000$27,000$24,000
Retained earnings (deficit)−$283.5M−$251.4M−$221.5M−$189.8M−$184.6M−$168.2M−$154.6M
Accumulated other comprehensive income$9,000$64,000$14,000$2,000$2,000$2,000$2,000
Total shareholders' equity$11.5M$26.3M$19.5M−$35.8M−$33.1M−$22.7M−$24.8M
Key figures
Total debt$1.7M$1.9M$2.5M$26.4M$25.3M$26.1M$18.0M
Net cash (debt)$12.9M$29.0M$20.7M−$26.0M−$20.8M−$14.7M−$17.5M
Working capital$8.9M$24.6M$17.6M−$29.7M−$16.7M−$3.0M−$14.2M
Tangible book value$11.5M$26.3M$19.5M−$35.8M−$33.1M−$22.7M−$24.8M
Book value per share$0.31$0.84$0.80−$1.46−$1.40−$0.96−$1.05
Shares outstanding37.2M31.5M24.4M24.6M23.6M23.6M23.6M
Current ratio2.434.573.690.060.260.790.04
Quick ratio2.344.483.540.010.200.780.03
Debt / equity0.150.070.13————
Equity / assets60.7%75.7%69.8%−647.0%−407.5%−161.7%−756.2%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 19, 2026); data from EODHD.

GNLX financial position

At the end of fiscal 2025 (December 31, 2025), Genelux had total assets of $19.0 million (down 45.2% from a year earlier), total liabilities of $7.5 million and shareholders' equity of $11.5 million. It held $14.6 million in cash and short-term investments against $1.7 million of debt, a net cash position of $12.9 million. Its current ratio was 2.43. In the latest quarter (ended June 30, 2026) total assets were $26.2 million and equity $16.1 million.

Related: GNLX income statement, GNLX cash flow statement, GNLX key metrics. See the GNLX stock overview for the latest quote and news.

GNLX balance sheet FAQ

What are Genelux's total assets?

Genelux reported total assets of $19.0 million at the end of fiscal 2025 (December 31, 2025), compared with $34.7 million a year earlier.

How much debt does Genelux have?

Genelux had $1.7 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.15.

How much cash does Genelux have?

Genelux held $14.6 million in cash and short-term investments at the end of fiscal 2025; with $1.7 million of debt that is net cash of $12.9 million.

What is Genelux's book value?

Genelux's shareholders' equity (book value) was $11.5 million at the end of fiscal 2025, or $0.31 per share.

What is Genelux's current ratio?

Genelux had current assets of $15.1 million and current liabilities of $6.2 million, a current ratio of 2.43 (it can cover its short-term obligations).

Biotechnology: balance sheet